Genasys Inc.
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
GNSS$1.41+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(in thousands, except par value and share amounts)
| March 31,2025 | September 30,2024 | |
|---|---|---|
| (Unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $5,667 | $4,945 |
| Short-term marketable securities | 1,409 | 7,945 |
| Restricted cash | 95 | 95 |
| Accounts receivable, net of allowance for credit losses of $65 | 3,623 | 3,283 |
| Inventories, net | 8,675 | 7,313 |
| Prepaid expenses and other | 3,951 | 2,559 |
| Total current assets | 23,420 | 26,140 |
| Long-term marketable securities | 130 | 249 |
| Long-term restricted cash | 585 | 250 |
| Property and equipment, net | 1,279 | 1,291 |
| Goodwill | 13,257 | 13,329 |
| Intangible assets, net | 7,301 | 8,506 |
| Operating lease right of use assets, net | 2,721 | 3,110 |
| Other assets | 1,028 | 1,061 |
| Total assets | $49,721 | $53,936 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $4,173 | $4,034 |
| Accrued liabilities | 17,401 | 9,030 |
| Operating lease liabilities, current portion | 1,047 | 1,021 |
| Total current liabilities | 22,621 | 14,085 |
| Notes payable, at fair value | 12,810 | 12,010 |
| Warrant liability | 3,220 | 6,640 |
| Deferred revenue, noncurrent | 287 | 369 |
| Operating lease liabilities, noncurrent | 2,727 | 3,269 |
| Total liabilities | 41,665 | 36,373 |
| Stockholders' equity: | ||
| Preferred stock, $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding | — | — |
| Common stock, $0.00001 par value; 100,000,000 shares authorized; 45,154,504 and 44,631,030 shares issued and outstanding as of March 31, 2025 and September 30, 2024, respectively | — | — |
| Additional paid-in capital | 126,520 | 125,690 |
| Accumulated deficit | (118,009) | (107,792) |
| Accumulated other comprehensive loss | (455) | (335) |
| Total stockholders' equity | 8,056 | 17,563 |
| Total liabilities and stockholders' equity | $49,721 | $53,936 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.